Veeva delivered robust financial results for Q4 and the full fiscal year 2026, exceeding revenue expectations and achieving a notable $3.195 billion in annual revenue, underscoring its position as a key player in the life sciences sector.

• Q4 total revenue reached $836 million, with non-GAAP operating income of $366 million.
• Full-year revenue of $3.195 billion signifies successful growth, surpassing the $3 billion run rate goal.
• Strategic partnerships in life sciences continue to strengthen, driven by demand for modernization and automation solutions.
• While AI interest is growing among clients, the primary demand is for scalable core systems rather than AI-specific solutions.
• CRM’s contribution to revenue is projected to decrease to about 10% by 2030, driven by a diverse business model and additional revenue from new product offerings.